ProSciento lands new alliance focused on metabolic disease

ProSciento lands new alliance focused on metabolic disease

June 4, 2015 – ProSciento Inc. will collaborate with Denmark-based Gubra ApS, a metabolic preclinical and drug discovery company, to discover and translate into clinical research novel drug targets, compounds and biomarkers addressing metabolic disease.
Read the full article at Outsourcing-Pharma.com »